Marco Mor
Dipartimento Farmaceutico
Università degli Studi di Parma
Italy
Name/email consistency: high
- Recent advances in the development of melatonin MT(1) and MT(2) receptor agonists. Mor, M., Rivara, S., Pala, D., Bedini, A., Spadoni, G., Tarzia, G. Expert. Opin. Ther. Pat (2010)
- Pharmacological tools in endocannabinoid neurobiology. Mor, M., Lodola, A. Curr. Top. Behav. Neurosci (2009)
- Application of 3D-QSAR in the rational design of receptor ligands and enzyme inhibitors. Mor, M., Rivara, S., Lodola, A., Lorenzi, S., Bordi, F., Plazzi, P.V., Spadoni, G., Bedini, A., Duranti, A., Tontini, A., Tarzia, G. Chem. Biodivers. (2005)
- Synthesis, biological activity, QSAR and QSPR study of 2-aminobenzimidazole derivatives as potent H3-antagonists. Mor, M., Bordi, F., Silva, C., Rivara, S., Zuliani, V., Vacondio, F., Rivara, M., Barocelli, E., Bertoni, S., Ballabeni, V., Magnanini, F., Impicciatore, M., Plazzi, P.V. Bioorg. Med. Chem. (2004)